استمتع بـUnlimited مع Magzter GOLD
احصل على وصول غير محدود إلى أكثر من 9000 مجلة وصحيفة وقصة مميزة مقابل
يحاول ذهب - حر
Does US cancer drug nod make Cipla attractive?
April 18, 2025
|Mint New Delhi
Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches
Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?
"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."
هذه القصة من طبعة April 18, 2025 من Mint New Delhi.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint New Delhi
Mint New Delhi
Tobacco cess set to expire, enter health and national security cess
Finance minister Nirmala Sitharaman will introduce a bill in Lok Sabha on Monday to levy a new cess for public health and national security, replacing the GST compensation cess on tobacco, which will lapse when the Centre completes repayment of the loans raised to compensate states.
2 mins
December 01, 2025
Mint New Delhi
China used to be a cash cow for western companies. Now it’s a test lab.
For Western companies in China, a new reality has set in: The easy money is gone and competition is only getting fiercer.
4 mins
December 01, 2025
Mint New Delhi
BEHIND THE GLOSSY REPORT: THE MAKE BELIEVE ESG WORLD
Recently, the Sebi chairperson made a distinction that should make every company board squirm, Speaking at the “Gatekeepers of Governance’ summit, Tuhin Kanta Pandey separated “compliance” from “governance” in a way that was both elegant and damning.
2 mins
December 01, 2025
Mint New Delhi
Battery PLI may get new spark as rules set to ease
Scheme saw limited success; 50GWh capacity by Dec 2024 goal fell far short
3 mins
December 01, 2025
Mint New Delhi
Why MF vendors haven't grown as fast as MF assets
A rising tide does not lift all boats—an adage that mutual fund distributors will vouch for.
4 mins
December 01, 2025
Mint New Delhi
New safety, emission rules spell riches for parts firms
Anti-lock brakes? Sound alerts for EVs? Ever-changing emission norms? For India’s nimble auto parts makers, every new regulation to raise safety and lower pollution is opening up business avenues.
3 mins
December 01, 2025
Mint New Delhi
Smart GDP growth casts shadow over December rate cut
The Reserve Bank of India’s (RBI's) Monetary Policy Committee (MPC) is widely expected to keep the policy rate unchanged on 5 December, even as a sizable minority of economists argues that the space created by softening inflation and moderating nominal growth warrants another rate cut.
2 mins
December 01, 2025
Mint New Delhi
Early-stage funding climbs back, led by bigger cheques
This year's fundraising average is likely to surpass 2022, with more deals yet to be reported
2 mins
December 01, 2025
Mint New Delhi
Opec+ retains pause on oil supply hikes
The Organization of the Petroleum Exporting Countries and its partners (Opec+) will stick with plans to pause production increases during the first quarter, delegates said, amid growing signs of a surplus in global oil markets.
1 min
December 01, 2025
Mint New Delhi
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Listen
Translate
Change font size